Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04671212 · ClinicalTrials.gov registry record
Discarded Bone Marrow for Hematology Research
A clinical trial of Hemoglobinopathies, sponsored by St. Jude Children's Research Hospital.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT04671212 is a study of Hemoglobinopathies that is actively recruiting participants, run by St. Jude Children's Research Hospital. The registered enrollment target is 50 participants, below the 1,801-participant average among 17 other Hemoglobinopathies trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04671212, a study of Hemoglobinopathies, is actively recruiting participants, sponsored by St. Jude Children's Research Hospital.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to establish a mechanism to obtain discarded bone marrow-containing bone samples from hemoglobinopathy, as well as non-hemoglobinopathy individuals. The processing of samples will help to understand how best to manipulate HSPC's from hemoglobinopathy patients with gene therapy and gene technologies in the laboratory environment. It will also allow us to establish a reservoir of samples that can be studied in the future to assess cellular function and fitness for transplant. Secondary objectives * To develop gene transfer and gene editing strategies as potentially curative therapy for hemoglobinopathies (e.g. sickle cell disease (SCD) and β-thalassemia). * To develop a drug treatment strategy which elevates the expression of fetal hemoglobin to a potentially curative level for hemoglobinopathies. * To examine the biology of bone marrow cells isolated from patients with hemoglobinopathies.
Conditions Studied
Study Locations (1)
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-07-26 |
| Est. Completion | 2035-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04671212
The ClinicalTrials.gov registry entry for NCT04671212 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,801-participant average among 17 other Hemoglobinopathies trials with a reported enrollment target (97% lower). The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hemoglobinopathies appearing as the primary indexed condition, and to 0 interventions.
NCT04671212 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT04671212 about?
NCT04671212 is a clinical study titled "Discarded Bone Marrow for Hematology Research". The primary objective of this study is to establish a mechanism to obtain discarded bone marrow-containing bone samples from hemoglobinopathy, as well as non-hemoglobinopathy individuals. The processing of samples will help to understand how best to manipulate HSPC's from hemoglobinopathy patients w...
What is the current status of trial NCT04671212?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2022-07-26. Estimated completion is 2035-01.
What conditions does trial NCT04671212 study?
This clinical trial studies the following conditions: Hemoglobinopathies.
Who is sponsoring clinical trial NCT04671212?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04671212 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemoglobinopathies
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
RECRUITING · Phase 1
-
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
RECRUITING · NA
-
Allo HSCT for High Risk Hemoglobinopathies
RECRUITING · Phase 2
-
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
RECRUITING · Phase 1
-
Study of the Role of Genetic Modifiers in Hemoglobinopathies
RECRUITING
-
Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.